Validation of the MAAPE Score for Predicting Clinical Outcomes in Hepatocellular Carcinoma Treated With Selective Internal Radiation Therapy
Journal of Medical Imaging and Radiation Oncology · 11.11.2026
DOI: 10.1111/1754-9485.70219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 11.11.2026. Verfasst von Yifan Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Austin Hospital, Melbourne, Victoria, Australia. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Selective internal radiation therapy (SIRT) is an established treatment option for hepatocellular carcinoma (HCC); however, patient selection remains challenging. The MAAPE score (MELD, Albumin, AFP, PVTT, ECOG) was recently developed as a prognostic tool. This study aimed to provide an independent, single‐centre external validation of the MAAPE score in predicting clinical outcomes for patients treated with Yttrium‐90 SIRT.
Methods
A retrospective analysis of patients with HCC treated with SIRT at a tertiary centre in Australia between 2012 and 2024 was performed. All patients received SIRT as first‐line treatment. Patients were stratified into Good, Average, and Poor prognosis groups based on their pre‐treatment MAAPE score. Tumour response and survival outcomes at 12 months were assessed as endpoints. Statistical analysis was performed using Kendall's rank correlation, Mann–Whitney tests, and Fisher's exact tests.
Results
A total of 64 patients were included, of whom 62 were evaluable for 12‐month survival. Patients were stratified into Good ( n = 18; 28.1%), Average ( n = 29; 45.3%), and Poor ( n = 17; 26.6%) prognosis groups. The MAAPE score demonstrated a significant correlation with 12‐month survival ( p = 0.008) and tumour response ( p = 0.030). Patients in the Good prognosis group achieved an 88.2% survival rate at 12 months, compared to 62.1% and 43.8% for the Average and Poor groups respectively. While correlations were statistically significant, pairwise comparisons between prognosis groups were only significant when comparing Good and Poor ( p = 0.010 for 12‐month survival and p = 0.046 for tumour response).
Conclusion
In this small single‐centre cohort, the MAAPE score identified patients with the most and least favourable 12‐month outcomes. It did not separate the adjacent prognosis groups from each other. These findings support the score at the extremes of risk, but they are preliminary. Larger prospective multicentre studies are required to assess the value of this score in personalised patient management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Austin Hospital, Melbourne, Victoria, Australia.
- School of Information Technology, Deakin University, Melbourne, Victoria, Australia.
ORCID-Profile: Yifan Ren, Anthony Tu Tran, Simon James, Dinesh Ranatunga, Kelvin Lim, Mark Goodwin
Zitieren
APA
Ren, Y., Tran, A. T., James, S., Owen, A., Ranatunga, D., Lim, K., Kutaiba, N., & Goodwin, M. (2026). Validation of the MAAPE Score for Predicting Clinical Outcomes in Hepatocellular Carcinoma Treated With Selective Internal Radiation Therapy. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.70219
Vancouver
Ren Y, Tran AT, James S, Owen A, Ranatunga D, Lim K, et al. Validation of the MAAPE Score for Predicting Clinical Outcomes in Hepatocellular Carcinoma Treated With Selective Internal Radiation Therapy. Journal of Medical Imaging and Radiation Oncology. 2026. doi:10.1111/1754-9485.70219
BibTeX
@article{Ren2026,
author = {Ren, Yifan and Tran, Anthony Tu and James, Simon and Owen, Andrew and Ranatunga, Dinesh and Lim, Kelvin and Kutaiba, Numan and Goodwin, Mark},
title = {Validation of the MAAPE Score for Predicting Clinical Outcomes in Hepatocellular Carcinoma Treated With Selective Internal Radiation Therapy},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2026},
doi = {10.1111/1754-9485.70219}
}
EUVIMED